- Home
- PDFS vs APLT Comparison
PDFS vs APLT Comparison
Compare PDFS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDFS
- APLT
- Stock Information
- Founded
- PDFS 1992
- APLT 2016
- Country
- PDFS United States
- APLT United States
- Employees
- PDFS N/A
- APLT N/A
- Industry
- PDFS EDP Services
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PDFS Technology
- APLT Health Care
- Exchange
- PDFS Nasdaq
- APLT Nasdaq
- Market Cap
- PDFS 1.2B
- APLT 971.6M
- IPO Year
- PDFS N/A
- APLT 2019
- Fundamental
- Price
- PDFS $29.98
- APLT $8.69
- Analyst Decision
- PDFS Strong Buy
- APLT Strong Buy
- Analyst Count
- PDFS 2
- APLT 5
- Target Price
- PDFS $41.00
- APLT $12.50
- AVG Volume (30 Days)
- PDFS 170.0K
- APLT 1.8M
- Earning Date
- PDFS 11-07-2024
- APLT 11-07-2024
- Dividend Yield
- PDFS N/A
- APLT N/A
- EPS Growth
- PDFS 56.69
- APLT N/A
- EPS
- PDFS 0.11
- APLT N/A
- Revenue
- PDFS $170,505,000.00
- APLT N/A
- Revenue This Year
- PDFS $11.20
- APLT N/A
- Revenue Next Year
- PDFS $23.75
- APLT $3,169.03
- P/E Ratio
- PDFS $272.45
- APLT N/A
- Revenue Growth
- PDFS 3.19
- APLT N/A
- 52 Week Low
- PDFS $27.69
- APLT $1.79
- 52 Week High
- PDFS $39.70
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PDFS 46.34
- APLT 46.34
- Support Level
- PDFS $29.90
- APLT $9.44
- Resistance Level
- PDFS $33.42
- APLT $10.62
- Average True Range (ATR)
- PDFS 1.17
- APLT 0.62
- MACD
- PDFS 0.10
- APLT -0.13
- Stochastic Oscillator
- PDFS 32.55
- APLT 14.95
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.